drugset / Trial / NCT04856969
Clinical Trial to Evaluate Pharmacokinetic Interaction of ATB-1011 and ATB-1012 in Healthy Adult Volunteers
Non-randomizedCrossoverOpen-labelTreatment
Summary
To evaluate the interaction between two investigational products by comparing and analyzing pharmacokinetic interactions and safety in steady state after multiple oral administration of ATB-1011 or ATB-1012 alone or in combination in healthy adult volunteers.
Timeline
- Start
- 2021-03-30
- Primary completion
- 2021-05-04
- Completion
- 2021-05-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dapagliflozin | Small molecule | — | — |
| Comparator | Olmesartan | Other / unclassified | — | — |
Indications
No indication recorded.